These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

662 related items for PubMed ID: 15665655

  • 1. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.
    Hillman JJ, Zuckerman IH, Lee E.
    J Womens Health (Larchmt); 2004 Nov; 13(9):986-92. PubMed ID: 15665655
    [Abstract] [Full Text] [Related]

  • 2. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H, Stevenson J.
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [Abstract] [Full Text] [Related]

  • 3. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
    Modena MG, Sismondi P, Mueck AO, Kuttenn F, Lignières Bd, Verhaeghe J, Foidart JM, Caufriez A, Genazzani AR, TREAT.
    Maturitas; 2005 Sep 16; 52(1):1-10. PubMed ID: 15963666
    [Abstract] [Full Text] [Related]

  • 4. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H.
    Climacteric; 2003 May 16; 6 Suppl 1():11-36. PubMed ID: 12945798
    [Abstract] [Full Text] [Related]

  • 5. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA.
    Climacteric; 2007 Oct 16; 10 Suppl 2():27-31. PubMed ID: 17882669
    [Abstract] [Full Text] [Related]

  • 6. Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication.
    Guay MP, Dragomir A, Pilon D, Moride Y, Perreault S.
    Pharmacoepidemiol Drug Saf; 2007 Jan 16; 16(1):17-27. PubMed ID: 16794994
    [Abstract] [Full Text] [Related]

  • 7. Osteoporosis management in a Medicaid population after the Women's Health Initiative study.
    Lee E, Wutoh AK, Xue Z, Hillman JJ, Zuckerman IH.
    J Womens Health (Larchmt); 2006 Mar 16; 15(2):155-61. PubMed ID: 16536679
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
    Kang BM, Kim MR, Park HM, Yoon BK, Lee BS, Chung HW, Cho SH, Choi H, Kim JG.
    Menopause; 2006 Mar 16; 13(1):125-9. PubMed ID: 16607108
    [Abstract] [Full Text] [Related]

  • 10. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
    Anderson GL, Chlebowski RT, Rossouw JE, Rodabough RJ, McTiernan A, Margolis KL, Aggerwal A, David Curb J, Hendrix SL, Allan Hubbell F, Khandekar J, Lane DS, Lasser N, Lopez AM, Potter J, Ritenbaugh C.
    Maturitas; 2006 Sep 20; 55(2):103-15. PubMed ID: 16815651
    [Abstract] [Full Text] [Related]

  • 11. Impact of WHI conclusions and ACOG guidelines on clinical practice.
    Gass M.
    Int J Fertil Womens Med; 2003 Sep 20; 48(3):106-10; discussion 137-8. PubMed ID: 12839140
    [Abstract] [Full Text] [Related]

  • 12. Effect of the Women's Health Initiative on osteoporosis therapy and expenditure in Medicaid.
    Udell JA, Fischer MA, Brookhart MA, Solomon DH, Choudhry NK.
    J Bone Miner Res; 2006 May 20; 21(5):765-71. PubMed ID: 16734392
    [Abstract] [Full Text] [Related]

  • 13. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
    Prescrire Int; 2004 Jun 20; 13(71):106-9. PubMed ID: 15233153
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [After the early termination of the Women's Health Initiative study. New American recommendations for postmenopausal hormone therapy].
    Stjernquist M, North American Menopause Society (NAMS) Advisory Panel.
    Lakartidningen; 2003 May 15; 100(20):1790-7. PubMed ID: 12806859
    [Abstract] [Full Text] [Related]

  • 16. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
    Barber CA, Margolis K, Luepker RV, Arnett DK.
    J Womens Health (Larchmt); 2004 Nov 15; 13(9):975-85. PubMed ID: 15665654
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
    Clanget C, Hinke V, Lange S, Fricke R, Botko R, Pfeilschifter J.
    Exp Clin Endocrinol Diabetes; 2005 Oct 15; 113(9):529-33. PubMed ID: 16235155
    [Abstract] [Full Text] [Related]

  • 19. Effect of the Women's Health Initiative study publication on hormone replacement therapy use among women who have undergone BRCA1/2 testing.
    Dorval M, Vallée MH, Plante M, Chiquette J, Gaudet M, Simard J.
    Cancer Epidemiol Biomarkers Prev; 2007 Jan 15; 16(1):157-60. PubMed ID: 17220345
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.